Acceleron Pharma Stock Predictions

Buy 0A3

*Your capital is at risk

159.00€

+0 (+0%)

At Close: Aug 17, 2022

Currently predicting for Mon, 6 Jul 2026

0A3.F Live board

Community Bull/Bear

Target Next close

Join the 0A3.F prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

0A3.F Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For 0A3.F

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

0A3.F Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	EUR target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT ACCELERON PHARMA INC.

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
B BXDC $21.71	1.11%	Jun 29
SRPT $17.02	13.28%	Jun 29
OSIS $218.29	1.59%	Jun 26
NMRK $15.02	4.66%	Jun 24
JLL $299.78	9.23%	Jun 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by